What does CUSIP 87164F105 represent in this 13F holders report?

CUSIP 87164F105 is the security identifier for SNDX - Syndax Pharmaceuticals Inc - Common Stock used to aggregate holder disclosures.

How many institutions held SNDX - Syndax Pharmaceuticals Inc - Common Stock in Q2 2023?

165 institutional investors reported SNDX - Syndax Pharmaceuticals Inc - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Syndax Pharmaceuticals Inc - Common Stock (SNDX)

CUSIP: 87164F105

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 86,727,396
Total 13F shares: 70,660,286
Share change: -2,278,103
Total reported value: $1,478,899,897
Put/Call ratio: 202%
Price per share: $20.93
Number of holders: 165
Value change: -$48,383,346
Number of buys: 106
Number of sells: 60

Quarterly Holders Quick Answers

What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 87164F105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	8.1%	7,003,734	$147,918,861	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	5.7%	4,900,841	$103,505,761	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	4.5%	3,866,230	$81,654,538	—	31 Mar 2023	13F
Avidity Partners Management LP	13F	Company	4.5%	3,865,300	$81,635,136	—	31 Mar 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	4.3%	3,708,838	$78,330,659	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	4%	3,497,085	$73,858,436	—	31 Mar 2023	13F
Kynam Capital Management, LP	13F	Company	3.7%	3,205,986	$67,710,424	—	31 Mar 2023	13F
Avoro Capital Advisors LLC	13F	Company	3.1%	2,650,000	$55,968,000	—	31 Mar 2023	13F
JENNISON ASSOCIATES LLC	13F	Company	2.8%	2,416,454	$51,035,510	—	31 Mar 2023	13F
Paradigm Biocapital Advisors LP	13F	Company	2.6%	2,274,512	$48,037,693	—	31 Mar 2023	13F
Eversept Partners, LP	13F	Company	2.5%	2,209,057	$46,655,284	—	31 Mar 2023	13F
BVF INC/IL	13F	Company	2.5%	2,143,197	$45,264,321	—	31 Mar 2023	13F
PFM Health Sciences, LP	13F	Company	2.2%	1,946,652	$41,113,290	—	31 Mar 2023	13F
ORBIMED ADVISORS LLC	13F	Company	2%	1,711,675	$36,150,576	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	1.8%	1,579,669	$33,362,609	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.5%	1,320,225	$27,882,212	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	1,227,601	$25,926,940	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	1.3%	1,093,844	$23,101,986	—	31 Mar 2023	13F
Sofinnova Investments, Inc.	13F	Company	1.2%	1,075,424	$22,712,955	—	31 Mar 2023	13F
Aisling Capital Management LP	13F	Company	1.2%	1,025,000	$21,648,000	—	31 Mar 2023	13F
T. Rowe Price Investment Management, Inc.	13F	Company	1.2%	1,000,715	$21,136,000	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	1.1%	981,886	$20,737,432	—	31 Mar 2023	13F
Nantahala Capital Management, LLC	13F	Company	1.1%	975,705	$20,606,890	—	31 Mar 2023	13F
BRAIDWELL LP	13F	Company	1.1%	920,049	$19,431,435	—	31 Mar 2023	13F
Foresite Capital Management IV, LLC	13F	Company	1%	875,000	$18,480,000	—	31 Mar 2023	13F
Commodore Capital LP	13F	Company	0.98%	853,884	$18,034,030	—	31 Mar 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.91%	790,000	$16,684,800	—	31 Mar 2023	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.79%	683,061	$14,426,248	—	31 Mar 2023	13F
Palo Alto Investors LP	13F	Company	0.71%	612,600	$12,938,112	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.69%	594,924	$12,564,794	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.65%	560,415	$11,835,965	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.63%	549,085	$11,597,000	—	31 Mar 2023	13F
Walleye Capital LLC	13F	Company	0.63%	545,090	$11,512,301	—	31 Mar 2023	13F
Point72 Asset Management, L.P.	13F	Company	0.6%	524,400	$11,075,328	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.57%	490,773	$10,365,126	—	31 Mar 2023	13F
LORD, ABBETT & CO. LLC	13F	Company	0.56%	484,666	$10,236,000	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.54%	470,166	$9,929,906	—	31 Mar 2023	13F
DAFNA Capital Management LLC	13F	Company	0.52%	447,073	$9,442,182	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.46%	395,169	$8,345,970	—	31 Mar 2023	13F
683 Capital Management, LLC	13F	Company	0.45%	390,000	$8,236,799	—	31 Mar 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.39%	339,592	$7,172,183	—	31 Mar 2023	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.38%	330,000	$6,969,600	—	31 Mar 2023	13F
Ghost Tree Capital, LLC	13F	Company	0.37%	325,000	$6,864,000	—	31 Mar 2023	13F
Soleus Capital Management, L.P.	13F	Company	0.37%	322,600	$6,813,312	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.33%	282,883	$5,974,489	—	31 Mar 2023	13F
Steve M. Sabus	3/4/5	Chief Commercial Officer	— class O/S missing	220,000	$5,685,614	—	05 Dec 2022	3/4/5
TWO SIGMA ADVISERS, LP	13F	Company	0.3%	263,352	$5,561,994	—	31 Mar 2023	13F
Ensign Peak Advisors, Inc	13F	Company	0.27%	235,370	$4,971,014	—	31 Mar 2023	13F
S.c.a. Candriam	13F	Individual	0.29%	254,874	$4,954,636	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.24%	211,723	$4,471,590	—	31 Mar 2023	13F

Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q2 2023

As of 30 Jun 2023, Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by 165 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 70,660,286 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., STATE STREET CORP, Frazier Life Sciences Management, L.P., VANGUARD GROUP INC, Kynam Capital Management, LP, Avidity Partners Management LP, Avoro Capital Advisors LLC, ORBIMED ADVISORS LLC, and JENNISON ASSOCIATES LLC. This page lists 165 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

161

Q2 2023 holders

165

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.